• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类 MC4R 变体影响内吞作用、运输和二聚化,揭示了参与体重调节的多种细胞机制。

Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.

机构信息

University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

MRC Laboratory of Molecular Biology, Cambridge, UK.

出版信息

Cell Rep. 2021 Mar 23;34(12):108862. doi: 10.1016/j.celrep.2021.108862.

DOI:10.1016/j.celrep.2021.108862
PMID:33761344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7994375/
Abstract

The Melanocortin-4 Receptor (MC4R) plays a pivotal role in energy homeostasis. We used human MC4R mutations associated with an increased or decreased risk of obesity to dissect mechanisms that regulate MC4R function. Most obesity-associated mutations impair trafficking to the plasma membrane (PM), whereas obesity-protecting mutations either accelerate recycling to the PM or decrease internalization, resulting in enhanced signaling. MC4R mutations that do not affect canonical Gα protein-mediated signaling, previously considered to be non-pathogenic, nonetheless disrupt agonist-induced internalization, β-arrestin recruitment, and/or coupling to Gα, establishing their causal role in severe obesity. Structural mapping reveals ligand-accessible sites by which MC4R couples to effectors and residues involved in the homodimerization of MC4R, which is disrupted by multiple obesity-associated mutations. Human genetic studies reveal that endocytosis, intracellular trafficking, and homodimerization regulate MC4R function to a level that is physiologically relevant, supporting the development of chaperones, agonists, and allosteric modulators of MC4R for weight loss therapy.

摘要

黑皮质素 4 受体(MC4R)在能量平衡中起着关键作用。我们利用与肥胖风险增加或降低相关的人类 MC4R 突变来剖析调节 MC4R 功能的机制。大多数与肥胖相关的突变会损害向质膜(PM)的运输,而肥胖保护突变要么加速向 PM 的回收,要么减少内化,从而增强信号转导。先前被认为非致病性的不影响经典 Gα 蛋白介导信号转导的 MC4R 突变,尽管不影响激动剂诱导的内化、β-arrestin 募集和/或与 Gα 的偶联,但它们破坏了配体可及的位点,这些位点与 MC4R 与效应器的偶联以及 MC4R 同源二聚化有关,这被多种肥胖相关突变所破坏。人类遗传研究表明,内吞作用、细胞内运输和同源二聚化调节 MC4R 的功能,达到了与生理相关的水平,支持开发 MC4R 的伴侣蛋白、激动剂和别构调节剂,用于减肥治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/5c77fb00203a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/2016d1e08a50/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/8849f65d0349/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/9621ad1303b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/97954ec012e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/f1168405f962/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/5c77fb00203a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/2016d1e08a50/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/8849f65d0349/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/9621ad1303b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/97954ec012e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/f1168405f962/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f6/7994375/5c77fb00203a/gr6.jpg

相似文献

1
Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.人类 MC4R 变体影响内吞作用、运输和二聚化,揭示了参与体重调节的多种细胞机制。
Cell Rep. 2021 Mar 23;34(12):108862. doi: 10.1016/j.celrep.2021.108862.
2
Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.人类功能获得性 MC4R 变体显示信号转导偏向并预防肥胖。
Cell. 2019 Apr 18;177(3):597-607.e9. doi: 10.1016/j.cell.2019.03.044.
3
Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.黑皮质素-4受体信号传导的调节:激动剂介导的脱敏和内化。
Endocrinology. 2003 Apr;144(4):1301-14. doi: 10.1210/en.2002-220931.
4
MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.MC4R变异体在多个水平调节α-MSH和setmelanotide诱导的细胞信号传导。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2452-2466. doi: 10.1210/clinem/dgae210.
5
Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to α-melanocyte-stimulating hormone (α-MSH).组成型胆固醇依赖性内吞作用是黑素皮质素-4 受体(MC4R)维持其对α-促黑素细胞激素(α-MSH)反应性所必需的。
J Biol Chem. 2012 Jun 22;287(26):21873-90. doi: 10.1074/jbc.M112.346890. Epub 2012 Apr 27.
6
Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.六种天然存在的组成型活性突变型人促黑素皮质素-4受体中反向激动剂对MAPK的激活作用
Biochim Biophys Acta. 2013 Dec;1832(12):1939-48. doi: 10.1016/j.bbadis.2013.06.006. Epub 2013 Jun 18.
7
Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.三种不同配体下 MC4R 突变的差异信号特征。
Int J Mol Sci. 2020 Feb 12;21(4):1224. doi: 10.3390/ijms21041224.
8
The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.天然反向激动剂刺鼠相关蛋白诱导抑制蛋白介导的黑皮质素-3和-4受体的内吞作用。
J Biol Chem. 2006 Dec 8;281(49):37447-56. doi: 10.1074/jbc.M605982200. Epub 2006 Oct 14.
9
Obesity-associated mutant melanocortin-4 receptors with normal Gα coupling frequently exhibit other discoverable pharmacological and biochemical defects.肥胖相关的突变黑素皮质素-4 受体与正常 Gα 偶联常表现出其他可发现的药理学和生化缺陷。
J Neuroendocrinol. 2019 Oct;31(10):e12795. doi: 10.1111/jne.12795. Epub 2019 Oct 15.
10
Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.新型药效伴侣伊普森17对缺陷型促黑素细胞激素4受体(MC4R)细胞表面表达及信号传导的挽救作用
J Mol Endocrinol. 2014 Aug;53(1):17-29. doi: 10.1530/JME-14-0005. Epub 2014 Apr 29.

引用本文的文献

1
Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.替尔泊肽可使因黑皮质素4受体(MC4R)缺乏所致肥胖的患者体重减轻。
Nat Med. 2025 Aug 26. doi: 10.1038/s41591-025-03913-2.
2
IMPROVE 2023: The 2nd International Meeting on Pathway-Related Obesity: Vision & Evidence.IMPROVE 2023:第二届肥胖相关通路国际会议:愿景与证据
Clin Obes. 2025 Oct;15(5):e70029. doi: 10.1111/cob.70029. Epub 2025 Jul 31.
3
A calcium-sensing receptor dileucine motif directs internalization to spatially distinct endosomal signaling pathways.

本文引用的文献

1
GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.GLP-1 受体激动剂治疗因致病性同源性黑素皮质素 4 受体突变导致的病态肥胖和 2 型糖尿病:病例报告。
Cell Rep Med. 2020 Apr 21;1(1):100006. doi: 10.1016/j.xcrm.2020.100006.
2
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.MC4R 激动剂赛美曲肽治疗 LEPR 或 POMC 缺乏引起的重度肥胖患者的疗效和安全性:单臂、开放标签、多中心、3 期临床试验。
Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-970. doi: 10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30.
3
一种钙敏感受体双亮氨酸基序将内化导向空间上不同的内体信号通路。
iScience. 2025 May 13;28(6):112651. doi: 10.1016/j.isci.2025.112651. eCollection 2025 Jun 20.
4
High-resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery.黑素皮质素-4受体的高分辨率深度突变扫描可为药物发现提供靶点特征。
Elife. 2025 Apr 9;13:RP104725. doi: 10.7554/eLife.104725.
5
Identification and molecular characterization of missense mutations in orphan G protein-coupled receptor GPR61 occurring in severe obesity.严重肥胖中孤儿G蛋白偶联受体GPR61错义突变的鉴定及分子特征分析
Mol Pharmacol. 2025 Apr;107(4):100026. doi: 10.1016/j.molpha.2025.100026. Epub 2025 Mar 4.
6
Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology.研究G蛋白偶联受体信号传导及药理学的定量方法。
J Cell Sci. 2025 Jan 1;138(1). doi: 10.1242/jcs.263434. Epub 2025 Jan 15.
7
Obesity-associated MRAP2 variants impair multiple MC4R-mediated signaling pathways.肥胖相关的MRAP2变体损害多种MC4R介导的信号通路。
Hum Mol Genet. 2025 Mar 7;34(6):533-546. doi: 10.1093/hmg/ddaf005.
8
Exploring the therapeutic potential of precision medicine in rare genetic obesity disorders: a scientific perspective.从科学角度探索精准医学在罕见遗传性肥胖症中的治疗潜力。
Front Nutr. 2024 Dec 23;11:1509994. doi: 10.3389/fnut.2024.1509994. eCollection 2024.
9
The MRAP2 accessory protein directly interacts with melanocortin-3 receptor to enhance signaling.MRAP2辅助蛋白直接与黑皮质素-3受体相互作用以增强信号传导。
bioRxiv. 2024 Nov 6:2024.11.06.622243. doi: 10.1101/2024.11.06.622243.
10
Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity.肥胖个体中罕见基因变异、基因检测和基因治疗的最新进展。
Curr Obes Rep. 2024 Sep;13(3):626-641. doi: 10.1007/s13679-024-00567-y. Epub 2024 Jun 1.
Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window.
阿片类配体的内在效力及其对明显偏差、操作分析和治疗窗口的重要性。
Mol Pharmacol. 2020 Oct;98(4):410-424. doi: 10.1124/mol.119.119214. Epub 2020 Jul 14.
4
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.黑皮质素-4 受体激动剂 setmelanotide 治疗 Bardet-Biedl 综合征肥胖的效果。
Diabetes Obes Metab. 2020 Nov;22(11):2133-2140. doi: 10.1111/dom.14133. Epub 2020 Jul 22.
5
Determination of the melanocortin-4 receptor structure identifies Ca as a cofactor for ligand binding.确定黑皮质素-4 受体结构鉴定出 Ca 是配体结合的辅助因子。
Science. 2020 Apr 24;368(6489):428-433. doi: 10.1126/science.aaz8995.
6
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective.黑皮质素-4受体的信号转导与致病修饰:结构视角
Front Endocrinol (Lausanne). 2019 Jul 31;10:515. doi: 10.3389/fendo.2019.00515. eCollection 2019.
7
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation.当前对黑素皮质素 4 受体激活的机制和药效动力学理解。
Molecules. 2019 May 16;24(10):1892. doi: 10.3390/molecules24101892.
8
Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.人类功能获得性 MC4R 变体显示信号转导偏向并预防肥胖。
Cell. 2019 Apr 18;177(3):597-607.e9. doi: 10.1016/j.cell.2019.03.044.
9
Characterization of Rare Variants in MC4R in African American and Latino Children With Severe Early-Onset Obesity.鉴定非洲裔美国人和拉丁裔儿童中严重早发性肥胖症患者 MC4R 中的罕见变异。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2961-2970. doi: 10.1210/jc.2018-02657.
10
Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.β-arrestins 在 GPCR 信号转导中的多种作用已通过 siRNA 和 CRISPR/Cas9 阐明。
Sci Signal. 2018 Sep 25;11(549):eaat7650. doi: 10.1126/scisignal.aat7650.